Tumor pharmacokinetics (PK) and pharmacodynamics (PD) of SAR245409 (XL765) and SAR245408 (XL147) administered as single agents to patients with recurrent glioblastoma (GBM): An Ivy Foundation early-phase clinical trials consortium study Meeting Abstract

  

Authors:	Cloughesy, T. F.; Mischel, P. S.; Omuro, A. M. P.; Prados, M.; Wen, P. Y.; Wu, B.; Rockich, K.; Xu, Y.; Lager, J. J.; Mellinghoff, I. K.
Abstract Title:	Tumor pharmacokinetics (PK) and pharmacodynamics (PD) of SAR245409 (XL765) and SAR245408 (XL147) administered as single agents to patients with recurrent glioblastoma (GBM): An Ivy Foundation early-phase clinical trials consortium study
Meeting Title:	49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	15 Suppl.
Meeting Dates:	2013 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-05-20
Language:	English
ACCESSION:	WOS:000335419600673
PROVIDER:	wos
DOI:	10.1200/jco.2013.31.15_suppl.2012
Notes:	Meeting Abstract: 2012 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128639